Pharmacokinetic Study of a Novel Cannabidiol (CBD) Formulation in Healthy Volunteers

NCT07186283 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

PK in Healthy Volunteers

Interventions

DRUG: CBD soft-gel capsules 600 mg
DRUG: CBD soft-gel capsules 900 mg
DRUG: Epidyolex

Sponsor

NW PharmaTech Ltd